Work

In situ quantitative measurement of mRNA to predict response to trastuzumab in a cohort of metastatic breast cancer patients.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.573

Authors: Maria Vassilakopoulou, Jennifer Bordeaux, Veronique Neumeister, Huan Cheng, Kurt Schalper, Dimosthenis V. Skarlos, Dimitrios G. Pectasides, Nicholas Pavlidis, Angelos Koutras, Helena Linardou, Evangelia Razis, Mattheos Bobos, Vassiliki Kotoula, David Rimm, George Fountzilas, Amanda Psyrri

Institutions: Yale University, Yale Cancer Center, Hellenic Cooperative Oncology Group, National and Kapodistrian University of Athens

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011746805

Cites:

Cited by:

Related to: 10